The previously mentioned study by Cimmino et al. (2017) provided the evidence that ascorbic acid treatment is able to induce the restoration of TET2 function in various leukemia models, by blocking aberrant self-renewal and leukemia progression. The gene discussed is TET2; the disease is leukemia.